Skip to content
September is Sepsis Awareness Month, and the Biotechnology Innovation Organization (BIO) is partnering with Sepsis Alliance to spread the word about sepsis and provide […]
Sepsis Awareness Month: 3 things you need to know about sepsis Read More »
During a busy week in Congress, House legislation to support drug development for pediatric rare diseases moved forward with bipartisan support, and a Senate
Capitol Hill update: House advances PPRV reauthorization, Senate reviews IRA Read More »
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking diabetes and weight-loss medicines. Next week, he will hold a hearing
Market concentration allows pharmacy benefit managers (PBMs) to siphon off funds from our health care system while increasing costs to patients and reducing access
House hearing delves into antitrust problems of PBMs Read More »
Voters want to bolster American manufacturing across biopharmaceutical and biotechnology sectors, according to a new public opinion survey conducted by Morning Consult for the
New survey checks pulse on voters’ concerns for innovation and biomanufacturing Read More »
In the season opener of the I am BIO Podcast, Dr. David Fajgenbaum shares his journey from patient to scientist, explaining how his battle
I am BIO Podcast: How Dr. David Fajgenbaum saved his own life Read More »
Antimicrobial resistance (AMR) is one of the clear and present threats of our time, and if left unchecked could have dire consequences. In 2019,
BIO at the World AMR Congress: ‘We know we’re racing against time’ Read More »
As authorities reveal 19 people at a California music festival contracted Valley fever, a company making a Valley fever vaccine for dogs is set
What to know about Valley fever vaccine development Read More »
The first shipment of Jynneos mpox vaccines arrived in the Democratic Republic of Congo (DRC) on Sept. 5, according to vaccine maker Bavarian Nordic.
First mpox vaccines arrive in DRC, epicenter of the international emergency Read More »
Neuroene Therapeutics is developing mitochondrial-protective small molecules for epilepsy, Parkinson’s, and mitochondrial diseases. The company’s CEO Sherine Chan, Ph.D., co-founded Neuroene with medicinal chemist
BIO Start-Up Stadium 2024: Meet Emerging Company winner Neuroene Therapeutics Read More »
